Skip to main content
. Author manuscript; available in PMC: 2017 May 10.
Published in final edited form as: Stat Med. 2015 Dec 6;35(10):1595–1615. doi: 10.1002/sim.6819

Table 5.

An analysis of the repeated-measures outcome from the ExTENd SMART. LNT=lenient non-response definition. STRGT=stringent non-response definition. NTX=naltrexone+CBI. PLC=placebo+CBI.

Embedded DTR Estimate of AUC/16 SE of AUC/16
(LNT, TDM, NTX) 20.65 0.54
(LNT, TDM, PLC) 21.02 0.52
(LNT, UC, NTX) 20.83 0.56
(LNT, UC, PLC) 21.19 0.53
(STRGT, TDM, NTX) 20.18 0.56
(STRGT, TDM, PLC) 20.18 0.52
(STRGT, UC, NTX) 20.04 0.54
(STRGT, UC, PLC) 20.03 0.54